GSK525762 is a new drug being tested as a treatment for myeloma. It belongs to a class of drugs known as BET Inhibitors.
| SparkCures ID | 274 |
|---|---|
| Developed By | GlaxoSmithKline |
| Generic Name | GSK525762 |
| Treatment Classifications |
There are no resources, links or videos to display for this treatment.